Quick Contact

    News and Events

    2022/04/13

    BGI’s Nucleic Acid Analysis Software Receives CE-IVDD Marking

    BGI’s Nucleic Acid Analysis Software for Respiratory Pathogenic Microorganisms and Nucleic Acid Analysis Software for Pathogenic Microorganisms have recently been CE-IVDD approved.

    The Analysis Software for Respiratory Pathogenic Microorganisms can be used to analyze and interpret the sequencing data generated by BGI’s Nucleic Acid Detection Kit for Respiratory Pathogenic Microorganisms with Combinatorial Probe-Anchor Synthesis Technology. Applicable samples include bronchoalveolar lavage fluid, sputum, throat swab, nasal swab, and nasopharyngeal swab.

    The Analysis Software for Pathogenic Microorganisms is designed to analyze and interpret the sequencing data generated through Nucleic Acid Detection Kit for Pathogenic Microorganisms with Combinatorial Probe-Anchor Synthesis Technology. Peripheral blood, cerebrospinal fluid, bronchoalveolar lavage fluid, nasopharyngeal swab, fresh tissue, etc., are applicable to testing.

    Both software are dedicatedly developed to determine of infection situations in testing samples. In conjunction with epidemiological history, clinical examination, and laboratory findings, the analyzed results can assist and provide accurate information for the clinical diagnosis of pathogenic microorganisms such as bacteria, viruses, fungi, and parasites.

    Follow us
    微信二维码

    Don’t hesitate to contact us to request a quote or to talk more about your requirements and how we can support your needs.